When you order a research peptide, you’re trusting that what’s in the vial actually matches what’s on the label. A Certificate of Analysis (COA) is how that trust gets verified. It’s the analytical document that shows what was tested, how it was tested, and whether the compound meets expected research-grade standards. The problem is that most researchers look at a COA and don’t fully understand what they’re seeing. A purity percentage alone doesn’t tell the full story — and without context, it can be misleading. This guide breaks down what a COA actually contains, how purity is measured, how to interpret chromatograms, and what to look for when evaluating peptide quality.
If you’re new to peptide research, it may help to start with What Are Peptides or explore how compounds are produced in How Peptides Are Created: Natural vs Synthetic. Understanding how to read a COA is not just about quality control — it’s about protecting the integrity of your research.
Research Use Educational Framework
- Educational reference content only
- Analytical awareness concepts
- Research methodology considerations
- Non-clinical research context
What Is a COA?
A Certificate of Analysis (COA) is a laboratory-issued document that verifies the identity, purity, and composition of a specific batch of a compound. In peptide research, it serves as the primary validation tool confirming that what is in the vial matches what is expected.
Unlike general product specifications, a COA is batch-specific. This means it reflects the actual test results from a single production run, not a generic representation of the compound. This distinction is critical because even small variations in synthesis conditions can impact purity, stability, and impurity profiles.
A properly structured COA typically includes the compound name, batch number, molecular weight, purity percentage, and the analytical methods used to generate those results — most commonly HPLC and mass spectrometry. If you’re new to peptide structure and function, it’s helpful to understand the basics in What Are Peptides.
One of the most overlooked aspects of COAs is traceability. A credible supplier should be able to link a specific vial back to a specific batch and corresponding COA. Without that connection, the document has little real value in a research setting.
How Purity Is Measured — HPLC Explained
High-Performance Liquid Chromatography (HPLC) is the standard method used to measure peptide purity. Rather than directly “seeing” purity, HPLC separates the components of a sample and measures how much of each component is present.
As the sample moves through the column, compounds separate based on their chemical interactions with the stationary phase. Each component exits the column at a different time, producing a signal that forms a peak on a chromatogram.
The largest peak represents the target peptide, while smaller peaks represent impurities, incomplete sequences, or degradation byproducts. Purity is calculated as the percentage of total signal attributed to the main peak.
What makes HPLC especially important in peptide research is its sensitivity to small changes. Even slight degradation — caused by heat, moisture, or improper storage — can alter the chromatogram. For a deeper understanding of how peptides break down over time, see Peptide Degradation and Half Life Explained.
This is why two peptides labeled with the same purity can behave very differently in research depending on how they were handled before testing.
FAQ — COA Red Flags and Documentation
What is the biggest red flag on a peptide COA?
The biggest red flag is a COA that is not batch-specific. If the same document is used across multiple products or batches, it likely does not reflect actual test results and should not be considered reliable.
Should a COA include a chromatogram image?
Yes. A legitimate COA should include the full chromatogram from HPLC testing, not just a reported purity percentage. The chromatogram allows you to visually assess impurities and overall sample quality.
Is third-party testing necessary for a reliable COA?
Third-party testing is strongly preferred because it provides independent verification. Internal lab results can be valid, but without external confirmation, there is less transparency and accountability.
What information should always be included in a COA?
A proper COA should include the compound name, batch number, test date, purity percentage, analytical methods used (such as HPLC and mass spectrometry), and supporting data like chromatograms.
Can a peptide still be low quality even with a high purity percentage?
Yes. A high purity percentage does not guarantee quality if the identity is not confirmed or if the COA lacks proper documentation. This is why both HPLC and mass spectrometry data are important.
How can I verify if a COA is legitimate?
Look for batch-specific data, detailed test results, and consistency across documentation. You can also compare COA structure and testing standards against guidance in How to Evaluate Peptide Vendors.
Mass Spectrometry — Confirming Identity
While HPLC measures purity, mass spectrometry (MS) confirms identity. It determines the molecular weight of the compound and compares it to the theoretical weight of the target peptide.
This distinction is critical because a sample can appear highly pure on HPLC but still be the wrong compound. HPLC tells you how clean the sample is — mass spectrometry tells you whether it is correct.
If the measured molecular weight matches the expected value, it confirms that the intended peptide sequence was successfully synthesized. If it does not, the sample may contain incorrect or incomplete sequences.
The most reliable COAs include both HPLC and MS data. Together, they provide a complete picture of compound quality — confirming both purity and identity.
This becomes especially important when comparing synthetic and naturally derived compounds, where small structural differences can impact biological behavior, as discussed in How Peptides Are Created: Natural vs Synthetic.
What Purity Percentages Actually Mean
Peptide purity is often simplified into a single number, but that number represents a distribution of compounds within a sample — not a guarantee of performance.
For example, a peptide labeled as 98% pure contains 2% impurities. Those impurities are not always inactive — they may include truncated sequences, modified amino acids, or degradation byproducts that can influence experimental outcomes.
In highly sensitive research settings, even small amounts of impurities can affect receptor binding, signaling pathways, and reproducibility. This is particularly relevant when studying mechanisms at the cellular level, where precision matters most. You can explore this further in How Peptides Work at the Cellular Level.
Higher purity generally leads to more consistent results, but purity alone is not enough — it must be supported by proper testing, storage, and handling practices.
Understanding what purity actually represents allows you to interpret COAs more accurately and avoid over-relying on a single metric.
Red Flags and What Good Documentation Looks Like
Not all COAs are equal. Some suppliers publish legitimate third-party tested documentation. Others publish internal documents with no way to verify the testing was performed independently. Knowing what good looks like helps you evaluate what you’re actually getting.
Good COA documentation includes: a specific batch number, the date testing was performed, the testing method used (HPLC, MS), the actual chromatogram image — not just a number, the purity result expressed as a percentage, and the molecular weight confirmed by mass spectrometry. Red flags include: no chromatogram image, no batch number, no testing date, purity claims without methodology, or a single COA applied to all batches of a compound. Transparency in documentation is one of the clearest signals of a supplier’s quality standards. For guidance on evaluating suppliers more broadly, see How to Evaluate Peptide Vendors.
- CONTINUE LEARNING
Explore Related Peptide Topics
Continue building your understanding by exploring related foundational peptide topics.